The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Kenyan Court Ruling Upholds Access to Generic Drugs

April 23, 2012

High Court Judge Mumbi Ngugi ruled Friday that lawmakers must revisit Kenya's Anti-Counterfeit Bill of 2008 to more clearly define the difference between generic and fake medicines. A previous court order had prevented the act from taking effect.

Three HIV patients filed suit in 2009, claiming the act was unconstitutional because it threatened the importation of life-saving medicines by confusing generics and fakes.

Generic drugs comprise the majority of medicines used in Kenya. Slightly more than 500,000 of the 1.5 million Kenyans living with HIV/AIDS have access to antiretroviral drugs, most of which are generics.

"The act is vague and could undermine access to affordable generic medicines since the act had failed to clearly distinguish between counterfeit and generic medicines," Ngugi said.

In a statement issued by Doctors Without Borders, petitioner Patricia Asero said the ruling "speaks against any ambiguity that serves to undermine access to generic medicines and puts the lives of people before profit."

Back to other news for April 2012

Adapted from:

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
HIV/AIDS Treatment in Kenya

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: